LHC Group, Inc. (LHCG) Expected to Post Quarterly Sales of $511.16 Million

Equities research analysts expect that LHC Group, Inc. (NASDAQ:LHCG) will post sales of $511.16 million for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for LHC Group’s earnings, with the highest sales estimate coming in at $516.50 million and the lowest estimate coming in at $494.38 million. LHC Group posted sales of $295.98 million during the same quarter last year, which would indicate a positive year over year growth rate of 72.7%. The firm is scheduled to issue its next quarterly earnings report after the market closes on Wednesday, May 8th.

On average, analysts expect that LHC Group will report full-year sales of $2.11 billion for the current financial year, with estimates ranging from $2.11 billion to $2.13 billion. For the next financial year, analysts forecast that the business will post sales of $2.22 billion, with estimates ranging from $2.19 billion to $2.27 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that follow LHC Group.

LHC Group (NASDAQ:LHCG) last announced its quarterly earnings data on Wednesday, February 27th. The health services provider reported $1.03 EPS for the quarter, meeting the Zacks’ consensus estimate of $1.03. The firm had revenue of $509.80 million for the quarter, compared to analyst estimates of $522.21 million. LHC Group had a return on equity of 8.40% and a net margin of 3.50%. The business’s quarterly revenue was up 75.1% compared to the same quarter last year. During the same period last year, the company earned $0.62 EPS.

Several research analysts have recently issued reports on LHCG shares. Zacks Investment Research lowered LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday, April 10th. BidaskClub lowered LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 27th. Barclays raised their price target on LHC Group from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 21st. Robert W. Baird raised their price target on LHC Group from $98.00 to $120.00 and gave the stock a “neutral” rating in a research report on Monday, March 4th. Finally, SunTrust Banks raised their price target on LHC Group to $130.00 and gave the stock a “buy” rating in a research report on Friday, March 1st. Six investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. LHC Group presently has an average rating of “Buy” and an average target price of $113.25.

In other LHC Group news, CEO Keith G. Myers sold 75,000 shares of LHC Group stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $108.53, for a total transaction of $8,139,750.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Keith G. Myers sold 11,558 shares of LHC Group stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $108.83, for a total value of $1,257,857.14. Following the transaction, the chief executive officer now owns 96,315 shares in the company, valued at $10,481,961.45. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 192,876 shares of company stock worth $20,614,290. Corporate insiders own 6.80% of the company’s stock.

A number of hedge funds have recently bought and sold shares of the business. BlackRock Inc. lifted its holdings in LHC Group by 2.7% during the fourth quarter. BlackRock Inc. now owns 4,566,337 shares of the health services provider’s stock worth $428,687,000 after acquiring an additional 121,385 shares in the last quarter. FMR LLC lifted its holdings in LHC Group by 24.9% during the fourth quarter. FMR LLC now owns 1,123,833 shares of the health services provider’s stock worth $105,506,000 after acquiring an additional 224,124 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in LHC Group by 2.9% during the third quarter. Bank of New York Mellon Corp now owns 732,075 shares of the health services provider’s stock worth $75,394,000 after acquiring an additional 20,567 shares in the last quarter. Norges Bank bought a new position in LHC Group during the fourth quarter worth about $51,535,000. Finally, Thrivent Financial for Lutherans lifted its holdings in LHC Group by 9.1% during the fourth quarter. Thrivent Financial for Lutherans now owns 530,693 shares of the health services provider’s stock worth $49,822,000 after acquiring an additional 44,450 shares in the last quarter. Hedge funds and other institutional investors own 93.46% of the company’s stock.

LHCG traded down $0.12 during mid-day trading on Friday, reaching $99.63. The stock had a trading volume of 727,519 shares, compared to its average volume of 258,876. The firm has a market capitalization of $3.12 billion, a price-to-earnings ratio of 28.06, a PEG ratio of 1.89 and a beta of 0.91. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.78 and a current ratio of 1.78. LHC Group has a 52 week low of $67.72 and a 52 week high of $115.54.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.

Further Reading: What is diluted earnings per share (Diluted EPS)?

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.